Search research articles
Contact Us
Filters
Showing results (21-30 of 166) with videos related to
Page
of 17
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity
|
March 24, 2018
The marketing of testosterone treatments for age-related low testosterone or 'Low T'
Barbara Mintzes
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
February 19, 2004
Antidepressants and adverse effects in young patients: uncovering the evidence
Andrew Herxheimer, Barbara Mintzes
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
November 24, 2004
Transparency in drug regulation: mirage or oasis?
Joel Lexchin, Barbara Mintzes
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique
|
August 2, 2005
Do higher drug costs lead to better health?
Barbara Mintzes, Joel Lexchin
Drug and Therapeutics Bulletin
|
October 29, 2021
'Drugs to avoid': can we improve prescribing appropriateness?
Barbara Mintzes, Agnes Vitry
Drug and Therapeutics Bulletin
|
December 1, 2022
Australia to lose agency dedicated to better quality medicine use
Barbara Mintzes, Agnes Vitry
Future Medicinal Chemistry
|
March 24, 2011
Direct-to-consumer advertising of prescription medicines: a counter argument
Barbara Mintzes, Dee Mangin
The Journal of Clinical Psychiatry
|
August 7, 2008
Does venlafaxine maintenance therapy prevent depression recurrences or drug discontinuation reactions?
Jon Jureidini, Barbara Mintzes
The American Journal of Psychiatry
|
November 5, 2008
Should paroxetine be used to treat depression during pregnancy?
Barbara Mintzes, Jon Jureidini
The International Journal of Risk & Safety in Medicine
|
November 26, 2014
A compromise too far: a review of Canadian cases of direct-to-consumer advertising regulation
Joel Lexchin, Barbara Mintzes
Page
of 17
Search research articles
Search
Showing results (21-30 of 166) with videos related to
Sort By:
Page
of 17
Current Opinion in Endocrinology, Diabetes, and Obesity
|
March 24, 2018
The marketing of testosterone treatments for age-related low testosterone or 'Low T'
Barbara Mintzes
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
February 19, 2004
Antidepressants and adverse effects in young patients: uncovering the evidence
Andrew Herxheimer, Barbara Mintzes
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
November 24, 2004
Transparency in drug regulation: mirage or oasis?
Joel Lexchin, Barbara Mintzes
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique
|
August 2, 2005
Do higher drug costs lead to better health?
Barbara Mintzes, Joel Lexchin
Drug and Therapeutics Bulletin
|
October 29, 2021
'Drugs to avoid': can we improve prescribing appropriateness?
Barbara Mintzes, Agnes Vitry
Drug and Therapeutics Bulletin
|
December 1, 2022
Australia to lose agency dedicated to better quality medicine use
Barbara Mintzes, Agnes Vitry
Future Medicinal Chemistry
|
March 24, 2011
Direct-to-consumer advertising of prescription medicines: a counter argument
Barbara Mintzes, Dee Mangin
The Journal of Clinical Psychiatry
|
August 7, 2008
Does venlafaxine maintenance therapy prevent depression recurrences or drug discontinuation reactions?
Jon Jureidini, Barbara Mintzes
The American Journal of Psychiatry
|
November 5, 2008
Should paroxetine be used to treat depression during pregnancy?
Barbara Mintzes, Jon Jureidini
The International Journal of Risk & Safety in Medicine
|
November 26, 2014
A compromise too far: a review of Canadian cases of direct-to-consumer advertising regulation
Joel Lexchin, Barbara Mintzes
Page
of 17